BodyBreak Joint Health Advanced
Natural health product licensed in Canada
- Licence holder
- BodyBreak Health Inc.
- NPN or DIN-HM
- 80035868
- Status
- Active licence
- Licence date
- 26 September 2012
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Rhizome Potency : 5 % Gingerols | 100 mg | Not calculated |
| Salix alba Source : Écorce (tige) Extraction ratio : 10:1 Dry plant equivalent : 500 mg Potency : 25 % Salicin | 50 mg | Not calculated |
| Collagène de type II hydrolysé Source : Cartilage de poulet | 30 mcg | Not calculated |
| L-Lysine Source : Chlorhydrate de L-lysine | 45 mg | Not calculated |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 13 mcg | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique | 15 mg | Not calculated |
| Boswellia serrata Source : Plante Potency : 65 % Boswellic acid | 20 mg | Not calculated |
| Acide d-pantothénique Source : D-pantothénate de calcium | 5 mg | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 350 mcg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, citrate de sodium, Dioxyde de silicium, Dextrine, Dextrose, Carboxyméthylcellulose de sodium, Microcrystalline cellulose, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Caplet | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. Helps in collagen formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80035868
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.